PMID: 9160078May 1, 1997Paper

Rhabdomyolysis associated with simvastatin-gemfibrozil therapy

Southern Medical Journal
A TalW Isley

Abstract

Simvastatin is a potent inhibitor of hydroxymethylglutaryl coenzyme A (HMG-CoA) reductase intended for use as a hypocholesterolemic agent. The long-term clinical experience with simvastatin indicates that it is a safe, effective, and well-tolerated hypolipidemic agent. Laboratory adverse events involving elevations of serum transaminase levels and serum creatine kinase (CK) levels to more than three times the upper limit of normal range have been seen in 1.5% and 3.4% of cases, respectively. We describe a case of severe myopathy and rhabdomyolysis associated with concomitant use of simvastatin and gemfibrozil. Seven days after discontinuing administration of gemfibrozil and simvastatin, the patient's condition improved and she was discharged home. Although this is the first report to indicate an association between myopathy and concomitant use of simvastatin and gemfibrozil, we strongly recommend caution and careful monitoring if simvastatin is given to patients receiving gemfibrozil.

Citations

Sep 17, 2009·European Journal of Clinical Pharmacology·Jianyong WuJianghua Chen
Apr 6, 1999·The American Journal of Cardiology·G W PogsonB G Carper
Feb 9, 2000·Pharmacology & Therapeutics·A CorsiniF Bernini
Feb 11, 2012·QJM : Monthly Journal of the Association of Physicians·S BhattacharyyaA Maitra
Apr 22, 2006·Cardiology in Review·Maria P Solano, Ronald B Goldberg
Jul 14, 2009·Southern Medical Journal·Dosha CumminsErica Baker
Oct 16, 2001·Drugs & Aging·B TomlinsonW Lan
Jan 20, 2004·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·James K KirklinDavid C McGiffin
Jan 20, 2004·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Michel Farnier
Jan 23, 2009·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Beatrice A Golomb, Marcella A Evans
Apr 10, 2002·Pharmacotherapy·Susan L RavnanKelli Haase
Apr 9, 2008·European Journal of Internal Medicine·Inbal AvisarEfrat Wolfovitz
Aug 11, 2007·International Journal of Cardiology·Socrates PastromasSpyridon Koulouris
Dec 14, 2004·International Journal of Clinical Practice·G De Angelis
Mar 9, 2005·Endocrinology and Metabolism Clinics of North America·Maria Del Pilar Solano, Ronald B Goldberg
Mar 21, 2007·The American Journal of Cardiology·Michael H DavidsonTerry A Jacobson
Dec 22, 2012·JACC. Cardiovascular Interventions·Steven P DunnDavid J Moliterno
Jul 6, 2000·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·M UcarR Dahlqvist
Feb 19, 2002·The Annals of Pharmacotherapy·Kevin B McDonaldMarc M Perreault
Oct 5, 2001·Journal of Cardiovascular Pharmacology and Therapeutics·M H Davidson
Nov 26, 2009·The Annals of Pharmacotherapy·Martin HahnM Shawn McFarland
Sep 25, 2004·Muscle & Nerve·Olavo M Vasconcelos, William W Campbell
May 16, 2000·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·E PlotkinZ Korzets
Oct 14, 2006·Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases·S GuptaL J Crofford
Sep 28, 2001·The Annals of Pharmacotherapy·M A OmarT S Cox
Jun 14, 2003·The Neurologist·Olaf StüveScott S Zamvil
Aug 4, 2001·The Annals of Pharmacotherapy·A Shek, M J Ferrill
Apr 9, 2002·The Annals of Pharmacotherapy·Bernardino RocaRafael Monferrer
Apr 30, 2002·The Annals of Pharmacotherapy·Jan L MaxaAlex Limanni
Feb 5, 2000·Neurologic Clinics·W S David

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.